Hotline:
+ 49 (0) 2204 2918806

Market studies for category Q

Items 1 to 10 of 17 total

  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    QuantRx Biomedical Corporation (QTXB) - Medical Equipment - Deals and Alliances Profile

    GlobalData
    19 Pages
    QuantRx Biomedical Corporation (QuantRx Biomedical) is a medical device company engaged in the development of products for advanced diagnosis of serious disease and health conditions. QuantRx Biomedical’s technology platforms are used for diagnostic testing to determine treatment as well as screening to identify a patient’s probabilit
    Englisch | Zukunftsanalyse | SKU: 159187
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Quinnova Pharmaceuticals, Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    17 pages
    Quinnova Pharmaceuticals, Inc. (Quinnova) is a pharmaceutical company. The company develops and commercializes prescription drug products based on dermal drug delivery platforms. Its products include atrapro, neosalus, salvax, hydro35, tersi and microcyn. The company’s atrapro product is used for the relief of pain, burning and itching
    Englisch | Zukunftsanalyse | SKU: 304038
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Quotient Bioresearch Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    Quotient Bioresearch Limited (QBL) is a pharmaceutical service provider. The company provides early stage and specialist drug development services. It provides services such as metabolism services, radiosynthesis services, bioanalytical sciences services and microbiology services. QBL caters to life science, pharmaceutical, biotechnology,
    Englisch | Zukunftsanalyse | SKU: 331467
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Q Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    19 pages
    Q Therapeutics, Inc. (Q Therapeutics) is a biopharmaceutical company. It develops adult stem cell therapies for debilitating diseases of the central nervous system (CNS). The company's lead product Q-Cells, is developed for treating diseases such as amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, cerebral palsy, sp
    Englisch | Zukunftsanalyse | SKU: 359752
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Quality Systems, Inc. (QSII) - Medical Equipment - Deals and Alliances Profile

    GlobalData
    25 pages
    Quality Systems, Inc. (QSI) is a healthcare IT service provider. The company develops and markets practice management and electronic health records (EHR) solutions. It works through its QSI Division and subsidiaries NextGen Healthcare Information Systems, Inc. The company’s solutions include medical which serves mid-large sized group pr
    Englisch | Zukunftsanalyse | SKU: 298216
  7. $1,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    QuadraMed Corporation Market Share Analysis

    GlobalData
    45 pages
    Introduction GlobalData’s new report, “QuadraMed Corporation Market Share Analysis” provides in-depth information on QuadraMed Corporation.’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is sup
    Englisch | Report | SKU: 325456
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    QR Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    QR Pharma, Inc. (QR Pharma) is a pharmaceutical company. The company develops novel drugs for the treatment of Alzheimer's disease, Parkinson’s disease and neurodegenerative disorders. Its products include posiphen and bisnorcymserine. QR Pharma’s posiphen inhibits the translation of amyloid precursor protein. The company bisnorcymser
    Englisch | Zukunftsanalyse | SKU: 342730
  9. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Qiagen Marseille SA (ALIPS) - Medical Equipment - Deals and Alliances Profile

    GlobalData
    29 Pages
    Qiagen Marseille SA (Qiagen) is an immunodiagnostic company. The company develops and markets molecular diagnostic tests. It also offers assistance for patients and oncologists in taking decisions for the complex therapeutic problems. The company’s products include AML1-ETO, BAALC, BCR-ABL Mbcr, BCR-ABL mbcr, CBFß-MYH11, CLLU1, E2A-PBX
    Englisch | Zukunftsanalyse | SKU: 159290
  10. $250.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Qassim Cement Company (3040) - Financial and Strategic SWOT Analysis Review

    GlobalData
    23 Pages
    Qassim Cement Company (3040) - Financial and Strategic SWOT Analysis Review Summary Qassim Cement Company (Qassim Cement) is a construction material manufacturer. The company manufactures cement and related products. The key products that the company offers include Ordinary Portland Cement, Sulphate Resistant Cement and Limestone Cement
    Englisch | Strategy and SWOT Report | SKU: 120818
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Quark Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    21 pages
    Quark Pharmaceuticals, Inc. (Quark) is a pharmaceutical company. The company discovers and develops novel therapeutic RNAi drug candidates. Its products pipeline include PF-655 (RTP801i14), QPI 1002(I5NP) and QPI 1007. These products are developed to cater to diseases, namely, diabetic macular edema, acute kidney injury (AKI), delayed gra
    Englisch | Zukunftsanalyse | SKU: 331778

Items 1 to 10 of 17 total